Keywords: AstraZeneca, Cost efficient health care, Health record, IMS Health, Clinical outcomes

AstraZeneca links with IMS on real-world evidence

Article | 11 January 2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) has entered into a three-year collaboration agreement with health care information provider IMS Health ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

AstraZeneca

Go to company listing